Aspen Aerogels (NYSE: ASPN) reported Q2 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $25.1 million versus the consensus estimate of $24.79 million.

GUIDANCE:

Aspen Aerogels sees Q3 2017 EPS of ($0.89)-($0.78), versus the consensus of ($0.88). Aspen Aerogels sees Q3 2017 revenue of $104-112 million, versus the consensus of $106.7 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.